Consensus is for FY24 revenue $8.6B. Sees FY24 Adjusted EBITDA $160M-$210M, $35M higher than the prior range of $125M-$175M. Additionally, the Company now projects a lower SG&A Expense Ratio in the range of 19.75%-20.25%, and a modestly higher Medical Loss Ratio in the range of 80.5%-81.5%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR: